Differentiation of Human Glioblastoma Stem Cells as a Prospective Tool to Find New Biomarkers and Molecular Targets: A Proteomic and Lipidomic Approach
Although glioblastoma stem cells (GSCs) constitute a small subpopulation of this highly heterogeneous brain cancer, they are widely recognised as key drivers of tumour recurrence after surgical resection and resistance to radiotherapy and chemotherapy. Differentiation of GSCs has, therefore, emerged as a strategy to in...